Related Experiment Video
Updated: May 23, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Renal dysfunction and CABG
Anthony M H Ho1, Simon K C Chan
1Department of Anaesthesia and Intensive Care, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, NT, Hong Kong, China. hoamh@hotmail.com
Abstract:
Renal dysfunction after coronary artery bypass grafting is common and is associated with increased morbidity and mortality. A number of strategies with potential renoprotective effects have been investigated, but no single one has been found to warrant routine use in CABG except fenoldopam in which the data to date appear promising. Other measures such as avoidance of nephrotoxic agents, including recent radiocontrast for coronary angiography, may reduce the incidence of renal dysfunction after cardiac surgery and should be implemented in routine care, whenever possible. The best renal protection strategy remains the same as for other organ protection and consists of optimizing haemodynamics, oxygenation, metabolic states and hydration.
Insights
Renal dysfunction is common after coronary artery bypass grafting (CABG). Optimizing hemodynamics, oxygenation, and hydration are key to renal protection, with fenoldopam showing promise.
Area of Science:
- Cardiology
- Nephrology
- Cardiovascular Surgery
Background:
- Renal dysfunction is a frequent complication following coronary artery bypass grafting (CABG).
- This complication significantly increases patient morbidity and mortality rates.
- Existing renoprotective strategies lack consistent efficacy for routine use.
Purpose of the Study:
- To review current strategies for preventing renal dysfunction post-CABG.
- To evaluate the efficacy of potential renoprotective agents and measures.
- To identify optimal practices for renal protection in cardiac surgery patients.
Main Methods:
- Literature review of studies investigating renoprotective strategies in CABG.
- Analysis of data on fenoldopam's potential renoprotective effects.
- Evaluation of measures like avoiding nephrotoxic agents and optimizing physiological parameters.
Main Results:
- No single renoprotective strategy is routinely recommended for CABG, with fenoldopam showing promising data.
- Avoiding nephrotoxic agents, such as radiocontrast, may reduce renal dysfunction incidence.
- Optimizing hemodynamics, oxygenation, metabolic state, and hydration are crucial for organ protection.
Conclusions:
- Comprehensive physiological optimization is the cornerstone of renal protection after CABG.
- Fenoldopam presents a promising option, warranting further investigation for routine use.
- Proactive avoidance of nephrotoxins is essential in perioperative care for cardiac surgery patients.
Related Concept Videos
Cardiac Catheterization I: Pre-Procedure Overview
Kidney Transplant II: Surgical Procedure
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Continuous Renal Replacement Therapy
Kidney Transplant I: Introduction
Heart Failure Drugs: Diuretics